Thane Wettig - Net Worth and Insider Trading

Thane Wettig Net Worth

The estimated net worth of Thane Wettig is at least $567,769 dollars as of 2024-05-15. Thane Wettig is the CEO of FibroGen Inc and owns about 471,178 shares of FibroGen Inc (FGEN) stock worth over $567,769. Details can be seen in Thane Wettig's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Thane Wettig has not made any transactions after 2024-03-07 and currently still holds the listed stock(s).

Transaction Summary of Thane Wettig

To

Thane Wettig Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Thane Wettig owns 1 companies in total, including FibroGen Inc (FGEN) .

Click here to see the complete history of Thane Wettig’s form 4 insider trades.

Insider Ownership Summary of Thane Wettig

Ticker Comapny Transaction Date Type of Owner
FGEN FibroGen Inc 2024-03-07 Chief Commercial Officer

Thane Wettig Latest Holdings Summary

Thane Wettig currently owns a total of 1 stock. Thane Wettig owns 471,178 shares of FibroGen Inc (FGEN) as of March 7, 2024, with a value of $567,769.

Latest Holdings of Thane Wettig

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FGEN FibroGen Inc 2024-03-07 471,178 1.21 567,769

Holding Weightings of Thane Wettig


Thane Wettig Form 4 Trading Tracker

According to the SEC Form 4 filings, Thane Wettig has made a total of 9 transactions in FibroGen Inc (FGEN) over the past 5 years, including 2 buys and 7 sells. The most-recent trade in FibroGen Inc is the acquisition of 50,000 shares on March 7, 2024, which cost Thane Wettig around $95,500.

Insider Trading History of Thane Wettig

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Thane Wettig Trading Performance

GuruFocus tracks the stock performance after each of Thane Wettig's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Thane Wettig is 6.29%. GuruFocus also compares Thane Wettig's trading performance to market benchmark return within the same time period. The performance of stocks bought by Thane Wettig within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Thane Wettig's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Thane Wettig

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -7.59
Relative Return to S&P 500(%) -7.89

Thane Wettig Ownership Network

Ownership Network List of Thane Wettig

No Data

Ownership Network Relation of Thane Wettig


Thane Wettig Owned Company Details

What does FibroGen Inc do?

Who are the key executives at FibroGen Inc?

Thane Wettig is the Chief Commercial Officer of FibroGen Inc. Other key executives at FibroGen Inc include director & Chief Executive Officer Enrique A Conterno , SVP & China Operations Christine Chung , and Chief Financial Officer Juan Graham .

FibroGen Inc (FGEN) Insider Trades Summary

Over the past 18 months, Thane Wettig made 8 insider transaction in FibroGen Inc (FGEN) with a net purchase of 29,738. Other recent insider transactions involving FibroGen Inc (FGEN) include a net sale of 92,477 shares made by Enrique A Conterno , a net sale of 39,779 shares made by Christine Chung , and a net sale of 19,563 shares made by Juan Graham .

In summary, during the past 3 months, insiders sold 0 shares of FibroGen Inc (FGEN) in total and bought 50,000 shares, with a net purchase of 50,000 shares. During the past 18 months, 255,701 shares of FibroGen Inc (FGEN) were sold and 50,000 shares were bought by its insiders, resulting in a net sale of 205,701 shares.

FibroGen Inc (FGEN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

FibroGen Inc Insider Transactions

No Available Data

Thane Wettig Mailing Address

Above is the net worth, insider trading, and ownership report for Thane Wettig. You might contact Thane Wettig via mailing address: C/o Fibrogen, Inc., 409 Illinois Street, San Francisco Ca 94158.

Discussions on Thane Wettig

No discussions yet.